Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Excluding the typical patient: thirty years of pharmacotherapy efficacy trials for obsessive-compulsive disorder.

Odlaug BL, Weinhandl E, Mancebo MC, Mortensen EL, Eisen JL, Rasmussen SA, Schreiber LR, Grant JE.

Ann Clin Psychiatry. 2014 Feb;26(1):39-46. Review.

2.

Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.

Murphy DL, Moya PR, Fox MA, Rubenstein LM, Wendland JR, Timpano KR.

Philos Trans R Soc Lond B Biol Sci. 2013 Feb 25;368(1615):20120435. doi: 10.1098/rstb.2012.0435. Review.

3.

Clinical predictors of drug response in patients with obsessive-compulsive disorder.

Kim CH, Jeong JW, Kim EJ, Shin YS, Suh HS, Lee HS, Koo MS.

Clin Psychopharmacol Neurosci. 2011 Apr;9(1):23-8. doi: 10.9758/cpn.2011.9.1.23.

4.

Comparison of treatment adherence between selective serotonin reuptake inhibitors and moclobemide in patients with social anxiety disorder.

Lim SW, Kwon YS, Ha J, Yoon HG, Bae SM, Shin DW, Shin YC, Oh KS.

Psychiatry Investig. 2012 Mar;9(1):73-9. doi: 10.4306/pi.2012.9.1.73.

5.

Obsessive compulsive disorder.

Soomro GM.

BMJ Clin Evid. 2012 Jan 18;2012. pii: 1004. Review.

6.

The neural bases of obsessive-compulsive disorder in children and adults.

Maia TV, Cooney RE, Peterson BS.

Dev Psychopathol. 2008 Fall;20(4):1251-83. doi: 10.1017/S0954579408000606. Review.

7.

Paroxetine treatment of compulsive hoarding.

Saxena S, Brody AL, Maidment KM, Baxter LR Jr.

J Psychiatr Res. 2007 Sep;41(6):481-7.

Supplemental Content

Support Center